Literature DB >> 16455424

What is the optimal clinical technique for measurement of left ventricular volume after myocardial infarction? A comparative study of 3-dimensional echocardiography, single photon emission computed tomography, and cardiac magnetic resonance imaging.

Jonathan Chan1, Carly Jenkins, Frederick Khafagi, Leanne Du, Thomas H Marwick.   

Abstract

BACKGROUND: Left ventricular (LV) volumes have important prognostic implications, but are commonly underestimated. We sought accuracy and reproducibility of LV volume measurement by live 3-dimensional (3D) echocardiography (3DE) and TI-201 single photon emission computed tomography (SPECT), compared with cardiac magnetic resonance imaging (MRI).
METHODS: In all, 30 patients (age 62 +/- 9 years, 23 men) underwent LV volume assessment with 3DE, SPECT, and cardiac MRI after myocardial infarction. LV volumes were measured using a semiautomated border detection algorithm for 3DE, gated SPECT software for SPECT, and a 3D display for MRI. Results of 3DE and SPECT volumes were compared with MRI as the standard of reference.
RESULTS: The 3DE volumes showed excellent correlation with cardiac MRI (end-diastolic volume [EDV], r = 0.90, P = .001; end-systolic volume [ESV], r = 0.94, P = .001), as did SPECT (EDV, r = 0.89, P = .001; ESV, r = 0.95, P = .001). However, both 3DE and SPECT underestimated LV volumes. The mean MRI EDV was 179 +/- 56 mL compared with 3DE (mean difference, -10 +/- 26 mL, P = .04) and SPECT (mean difference, -58 +/- 28 mL, P < .001). There was a significant difference between SPECT EDV and 3DE (mean difference, -48 +/- 31 mL, P < .001). The mean MRI ESV was 96 +/- 54 mL and this was underestimated by SPECT (mean difference, -22 +/- 19 mL, P < .001), but not by 3DE (mean difference, -0.9 +/- 19 mL, P = not significant). ESV was also underestimated when SPECT was compared with 3DE (mean difference, -22 +/- 27 mL, P < .001). The results of 3DE were reproducible with excellent intraobserver (ESV, r = 0.98, -2 +/- 6 mL; EDV, r = 0.98, -1 +/- 6 mL, P = .001) and interobserver (ESV, r = 0.97, -2 +/- 6 mL; EDV, r = 0.95, -3 +/- 10 mL, P = .001) correlation.
CONCLUSION: We have shown that 3DE is accurate and reproducible for the measurement of LV volumes for risk assessment in chronic ischemic heart disease and dilated cardiomyopathy. Furthermore, 3DE is more accurate than TI-201 SPECT with less underestimation of LV volumes.

Entities:  

Mesh:

Year:  2006        PMID: 16455424     DOI: 10.1016/j.echo.2005.08.020

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  23 in total

1.  Noninvasive modalities for the assessment of left ventricular function: all are equal but some are more equal than others.

Authors:  Tiong Keng Lim; Roxy Senior
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

2.  Three-dimensional echocardiography for evaluating left ventricular function in patients with ST elevation myocardial infarction: a pilot study.

Authors:  Adelaide M Arruda-Olson; Francesca Bursi; Yariv Gerber; Ronald H May; Véronique L Roger; Patricia A Pellikka
Journal:  Mayo Clin Proc       Date:  2008-03       Impact factor: 7.616

3.  Evaluation of left ventricular volumes and ejection fraction by gated SPECT and cardiac MRI in patients with dilated cardiomyopathy.

Authors:  Feng Wang; Jian Zhang; Wei Fang; Shi-Hua Zhao; Min-Jie Lu; Zuo-Xiang He
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-18       Impact factor: 9.236

4.  Gated SPECT: what's the ideal method to measure LVEF?

Authors:  Sum-Che Man; Ernst E van der Wall; Cees A Swenne
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-02       Impact factor: 2.357

5.  Development and validation of a new automatic algorithm for quantification of left ventricular volumes and function in gated myocardial perfusion SPECT using cardiac magnetic resonance as reference standard.

Authors:  Helen Soneson; Fredrik Hedeer; Carmen Arévalo; Marcus Carlsson; Henrik Engblom; Joey F A Ubachs; Håkan Arheden; Einar Heiberg
Journal:  J Nucl Cardiol       Date:  2011-07-15       Impact factor: 5.952

6.  Measurement of Ejection Fraction by Cardiac Magnetic Resonance Imaging and Echocardiography to Monitor Doxorubicin-Induced Cardiotoxicity.

Authors:  Tahir Tak; Camilla M Jaekel; Shahyar M Gharacholou; Marshall W Dworak; Scott A Marshall
Journal:  Int J Angiol       Date:  2019-10-11

Review 7.  Current Clinical Applications of Three-Dimensional Echocardiography: When the Technique Makes the Difference.

Authors:  Elena Surkova; Denisa Muraru; Patrizia Aruta; Gabriella Romeo; Jurate Bidviene; Diana Cherata; Luigi P Badano
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

8.  Comparison of cardiac magnetic resonance with gated SPECT for evaluation of left ventricular function and volumes in patients with severe and multiple myocardial perfusion defects.

Authors:  Ahmed Fathala
Journal:  J Saudi Heart Assoc       Date:  2010-07-21

9.  Semi-automated quantification of left ventricular volumes and ejection fraction by real-time three-dimensional echocardiography.

Authors:  Jøger Hansegård; Stig Urheim; Ketil Lunde; Siri Malm; Stein Inge Rabben
Journal:  Cardiovasc Ultrasound       Date:  2009-04-20       Impact factor: 2.062

10.  Visualization of coronary venous anatomy by cardiovascular magnetic resonance.

Authors:  John F Younger; Sven Plein; Andrew Crean; Stephen G Ball; John P Greenwood
Journal:  J Cardiovasc Magn Reson       Date:  2009-08-11       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.